License Territory Expanded: ARVN001 for UME
source: pixabay.com

License Territory Expanded: ARVN001 for UME

When it comes to pharmaceuticals, licensed territory helps ensure that drugs within a certain territory are offered to patients. Exclusive licenses sometimes mean that pharmaceuticals are only available in specific…

Continue Reading License Territory Expanded: ARVN001 for UME
Health Canada Approves Hyrimoz for Ankylosing Spondylitis
stevepb / Pixabay

Health Canada Approves Hyrimoz for Ankylosing Spondylitis

According to GlobeNewswire, Health Canada has approved of a biosimilar, Hyrimoz, to treat ankylosing spondylitis and eight other rare conditions. Sandoz Canada is excited about this approval, as it expands…

Continue Reading Health Canada Approves Hyrimoz for Ankylosing Spondylitis
Study Finds Disparities in Screening but Consistency in Treating Juvenile Localized Scleroderma in the UK
DarkoStojanovic / Pixabay

Study Finds Disparities in Screening but Consistency in Treating Juvenile Localized Scleroderma in the UK

According to a story from Scleroderma News, a recent study found that while treatment approaches for juvenile localized scleroderma were quite consistent in the UK, there were significant disparities in…

Continue Reading Study Finds Disparities in Screening but Consistency in Treating Juvenile Localized Scleroderma in the UK